4
Changes in Ownership
Kura Oncology, Inc. Filed Acc 0001193125-26-407935
Chief Commercial Officer sold 32,450 shares at an average $10.63 ($345,036)
From the SEC's structured data for this filing
Trades in this filing
Powl Brian T. · Chief Commercial Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-28 | Sale : show line 1 in the form | −9,020 | $10.50 | $94,686 | 160,249 | D |
| 2026-09-28 | Sale : show line 2 in the form | −8,000 | $10.56 | $84,498 | 152,249 | D |
| 2026-09-29 | Sale : show line 3 in the form | −15,430 | $10.75 | $165,852 | 136,819 | D |
| Open-market sales · 32,450 sh · avg $10.63 · $345,036 | ||||||
Loading xslF345X06/ownership.xml…